Clolar and Bactrim drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Clolar (clofarabine) and Bactrim (sulfamethoxazole; trimethoprim). Common drug interactions include device related infection among females and hypotension among males.
The phase IV clinical study analyzes what interactions people have when they take Clolar and Bactrim. It is created by eHealthMe based on reports of 47 people who take the same drugs from the FDA, and is updated regularly.
What is Clolar?
Clolar has active ingredients of clofarabine. eHealthMe is studying from 1,093 Clolar users. Check the latest studies of Clolar.
What is Bactrim?
Bactrim has active ingredients of sulfamethoxazole; trimethoprim. It is often used in urinary tract infection. eHealthMe is studying from 89,117 Bactrim users. Check the latest studies of Bactrim.
47 people who take Clolar and Bactrim together, and have interactions are studied.

What are the common drug interactions of Clolar and Bactrim, by gender? *:
female:
- Device related infection
- Lipase increased
- Pancreatitis (inflammation of pancreas)
- Pneumonia
- Anaemia (lack of blood)
- Thrombocytopenia (decrease of platelets in blood)
- Blood amylase increased
- Hypoxia (low oxygen in tissues)
- Neutropenic sepsis (whole body infection is caused by a condition in which the number of white blood cells (called neutrophils) in the blood is low. neutrophils help the body to fight infection)
- Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
male:
- Hypotension (abnormally low blood pressure)
- Thrombocytopenia (decrease of platelets in blood)
- Renal failure (kidney dysfunction)
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Aspergillosis (an infection caused by a fungus called aspergillus)
- Enterococcal bacteraemia (presence of bacteria lactic acid in the blood)
- Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
- Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
- Mucosal inflammation (infection of mucous membrane)
- Nocardiosis (an infectious disease affecting either the lungs or whole body)
What are the common drug interactions of Clolar and Bactrim, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
- Lipase increased
- Neutropenia (an abnormally low number of neutrophils)
- Device related infection
- Neutropenic infection (infection with less neutrophil numbers in blood)
- Pancreatitis (inflammation of pancreas)
- Pneumonia
- Blood amylase increased
- Hypoxia (low oxygen in tissues)
- Brain oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain)
- Staphylococcal bacteraemia (a bacterial infection of blood)
10-19:
- Hypotension (abnormally low blood pressure)
- Renal failure (kidney dysfunction)
- Febrile neutropenia (fever with reduced white blood cells)
- Pain in extremity
- Pyrexia (fever)
- Vomiting
- Anaemia (lack of blood)
- Lung neoplasm (tumour of lung)
- Mucosal inflammation (infection of mucous membrane)
- Oral herpes (viral infection of mouth)
20-29:
- Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
- Hypotension (abnormally low blood pressure)
- Abdominal pain
- Ascites (accumulation of fluid in the abdominal cavity)
- Cardiac arrest
- Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
- Enteritis (inflammation of the small intestine)
- Enterococcal bacteraemia (presence of bacteria lactic acid in the blood)
- Infusion related reaction
- Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
30-39:
- Hyperaesthesia
- Hypernatraemia (an abnormally high plasma concentration of sodium ions)
- Hypokalaemia (low potassium)
- Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
- Multi-organ failure (multisystem organ failure)
- Myalgia (muscle pain)
- Myositis (inflammation of the muscles)
- Nausea (feeling of having an urge to vomit)
- Nervous system disorder (a general class of medical conditions affecting the nervous system)
- Vomiting
40-49:
- Acute graft versus host disease (acute complication following an allogeneic tissue/blood transplant)
- Acute myeloid leukaemia recurrent (acute cancer in which the bone marrow makes abnormal myeloblast- recurrent)
- Cytomegalovirus infection
- Graft versus host disease in skin (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the skin)
50-59:
- Aphasia (damage to the parts of the brain that control language)
- Confusional state
- Dry mouth
- Fall
- Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
- Graft versus host disease in intestine (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body and damages intestinal mucosal membrane)
- Muscular weakness (muscle weakness)
- Proctalgia (pain in the rectum)
60+:
- Thrombocytopenia (decrease of platelets in blood)
- Renal failure (kidney dysfunction)
- Nocardiosis (an infectious disease affecting either the lungs or whole body)
- Small intestinal obstruction (blockage in small intestine)
- Transaminases increased
- Renal impairment (severely reduced kidney function)
- Cardiac arrest
- Coagulopathy (blood's ability to clot is impaired)
- Depressed level of consciousness
- Diastolic dysfunction
What are the existing conditions these people have? *
- Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 18 people, 38.30%
- Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 11 people, 23.40%
- Burkitt Lymphoma (cancer of the lymphatic system): 4 people, 8.51%
- Acute Myeloid Leukaemia Recurrent (acute cancer in which the bone marrow makes abnormal myeloblast- recurrent): 4 people, 8.51%
- Nausea (feeling of having an urge to vomit): 3 people, 6.38%
- Bone Marrow Conditioning Regimen: 3 people, 6.38%
- Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 3 people, 6.38%
- Acute Lymphocytic Leukaemia Recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent): 3 people, 6.38%
* Approximation only. Some reports may have incomplete information.
Do you take Clolar and Bactrim?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Clolar and Bactrim:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Clolar:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Bactrim:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Clolar and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Bactrim and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on clofarabine and sulfamethoxazole; trimethoprim (the active ingredients of Clolar and Bactrim, respectively), and Clolar and Bactrim (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Tacrolimus cause Cognitive Disorder? - 16 seconds ago
- Renal Injury and drugs of ingredients of cyclophosphamide - 33 seconds ago
- Diclofenac Potassium vs. Fentanyl-25, side effect and effectiveness comparison - 39 seconds ago
- Nephrogenic Anaemia and drugs of ingredients of quinapril hydrochloride - a minute ago
- Zemplar and Gastrointestinal Haemorrhage for Men aged 60+ - a minute ago
- Could Janumet cause Hyperbilirubinaemia Aggravated? - a minute ago
- Fever and drugs of ingredients of tafamidis meglumine - a minute ago
- Eligard and Prostatic Obstruction for Men aged 60+ - a minute ago
- Could Aranesp cause Arteriovenous Fistula Site Infection? - a minute ago
- Skyrizi and Heat Stroke for Men aged 20-29 - a minute ago